50mg Eltrombopag Tablets

50mg Eltrombopag Tablets Specification

Origin of Medicine
India

Salt Composition
Eltrombopag Olamine, equivalent to Eltrombopag 50mg

Packaging Type
Blister pack

Brand Name
Eltrombopag 50mg

Dosage Form
Oral tablet

Pacakaging (Quantity Per Box)
7 tablets per box

Life Span
24 months from manufacture date

Indication
For patients with low platelet counts due to chronic ITP, Hepatitis C, or severe aplastic anemia

Drug Type
Allopathic, Allopathic

Ingredients
Eltrombopag Olamine

Physical Form
Tablets, Tablets

Function
Thrombopoietin Receptor Agonist to increase platelet production, Platelet Increasing Agent

Recommended For
Thrombocytopenia in chronic immune (idiopathic) thrombocytopenic purpura (ITP), Hepatitis C-associated thrombocytopenia, Severe aplastic anemia

Dosage
As prescribed by physician, commonly 50mg once daily

Dosage Guidelines
Take with or without food, avoid dairy products or polyvalent cations within 4 hours of dose

Suitable For
Adults and as directed by physician, Suitable for adults and children

Quantity
7 tablets

Storage Instructions
Store below 30C, protected from moisture

Shape
Round

Side Effects
Nausea, diarrhea, headache, increased liver enzymes (refer to leaflet)

Warning
Not for use in patients with hypersensitivity to Eltrombopag

Colour
Brown

Prescription Required
Yes

Therapeutic Class
Hematology

Administration Route
Oral

Regulatory Approval
As per local regulatory authority

Marketed By
As specified on pack

Minimum Order Quantity
1 Box

50mg Eltrombopag Tablets Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 50mg Eltrombopag Tablets

Unlock the wondrous potential of Eltrombopag 50mg Tablets-meticulously crafted in India for incomparable value in hematological therapy. Utilise this lofty prescription solution to precisely increase platelet production in those facing chronic ITP, hepatitis C-associated thrombocytopenia, or severe aplastic anemia. Each round brown tablet delivers 50mg of Eltrombopag Olamine, presented in a sturdy blister pack for assured quality. This allopathic platelet increasing agent offers a world-class option, regulated and approved, to answer unique patient needs with efficacy and safety. Offer your patients renewed hope with Eltrombopag's unmatched value.

Directions and Application Areas for Eltrombopag 50mg Tablets

The 50mg Eltrombopag Tablets are intended for oral administration, taken by mouth as directed by a physician. Best utilised in the management of chronic immune thrombocytopenic purpura (ITP), hepatitis C-related low platelet counts, and severe aplastic anemia, these tablets offer targeted hematological support. Patients should adhere to prescribed dosages, typically one tablet daily, and avoid dairy or polyvalent cations within four hours of dosing to maximise therapeutic benefit.

Sample Policy, Packaging, and Supply Details for Eltrombopag 50mg Tablets

Our sample policy ensures that, upon request, representative units are dispatched promptly for qualified professionals. Packaging consists of secure blister packs, containing seven tablets per box, preserving potency and integrity during transit. With a steady supply ability across India, orders are shipped swiftly and handed over to trusted logistics partners, ensuring products reach customers efficiently and intact, maintaining optimum storage conditions throughout the journey.

FAQ's of 50mg Eltrombopag Tablets:

Q: How should I take 50mg Eltrombopag Tablets for best results?

A: Take the tablet orally, once daily as prescribed, with or without food. Avoid consuming dairy products or supplements containing polyvalent cations within four hours of your dose to ensure optimal absorption.

Q: What are the key benefits of using Eltrombopag 50mg Tablets?

A: Eltrombopag 50mg acts as a thrombopoietin receptor agonist, effectively increasing platelet production in conditions like chronic ITP, hepatitis C-associated thrombocytopenia, and severe aplastic anemia, improving platelet counts and reducing bleeding risk.

Q: When can I expect results after starting Eltrombopag treatment?

A: Responses vary, but many patients report improvements in platelet counts within one to two weeks of consistent, physician-directed usage. Always follow up regularly with your healthcare provider for monitoring.

Q: Where should Eltrombopag 50mg Tablets be stored?

A: Keep the tablets below 30C, away from moisture and direct heat. Retain them in their original blister packaging until use to maintain optimal efficacy and safety.

Q: What is the process for ordering and receiving Eltrombopag 50mg Tablets?

A: Contact your supplier or trader in India with a valid prescription. Orders are promptly dispatched, shipped in secure packaging, and handed over to reliable carriers to ensure safe and on-time delivery.

Q: Who should avoid taking Eltrombopag 50mg Tablets?

A: These tablets should not be used by individuals with known hypersensitivity to Eltrombopag or any of its components. Consult your doctor for a full list of precautions and eligibility.